Modotuximab

DB14827Investigational

Modotuximab is under investigation in clinical trial NCT03549338 (Sym004 Versus Futuximab or Modotuximab in Patients With mCRC).

Mechanism: Pharmacologically active on Epidermal growth factor receptor
Curator reviewed

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Modotuximab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.